- Thread starter
- Staff
- #1
Dadparvar
Staff member
- Nov 11, 2016
- 11,362
- 0
- 6
Human Rights Watch (HRW) on Sunday voiced concern regarding a South Korean proposal that would allow medication abortion in 2027, saying it includes overly restrictive regulations that continue to impair the rights of women and girls to safe and affordable reproductive healthcare services.
In a comprehensive public briefing, the organization examined the regulatory framework governing upcoming pharmaceutical approvals, warning that extensive administrative mandates threaten to undermine reproductive autonomy. HRW emphasized that while authorizing medical abortion pills represents a legal step forward following previous efforts to approve abortion pills for the first time, the proposed implementation rules impose unnecessary procedural barriers.
These restrictions include mandatory in-person multi-visit waiting periods, restrictive provider limitations, and third-party authorization requirements that disproportionately burden rural residents and adolescents seeking confidential care within a cultural landscape where reproductive healthcare has historically faced intense social stigma and institutional caution.
The debate over abortion access stems from the historic February 2019 decision by the Constitutional Court of Korea ruling that the criminalization of abortion violated women’s constitutional rights to bodily autonomy and privacy, ordering the legislature to enact a revised legal framework. Despite the constitutional mandate, legislative gridlock left a legal vacuum where abortion remained formally unregulated for years while remaining accessible under constrained clinical guidelines. The World Health Organization (WHO) classifies medical abortion drugs as essential medicines that can be safely managed through primary healthcare settings, establishing global standards that advocacy groups cite against local restrictions.
HRW highlighted that international human rights law protects access to safe and legal abortion as a fundamental component of the right to health, non-discrimination, and privacy. The organization urged the South Korean government to revise the 2027 regulatory proposal by removing mandatory hospitalization rules, eliminating spousal or parental consent obstacles, and ensuring that abortion medications are distributed through standard pharmaceutical channels without prohibitive pricing structures.
For additional background on the legal evolution of reproductive rights in the region, previous reporting examines the ongoing implementation hurdles following the Constitutional Court of Korea striking down criminal abortion laws.
The post Human Rights Watch criticizes restrictive regulations in South Korean medication abortion proposal appeared first on JURIST - News.
Continue reading...
Note: We don't have any responsibilities about this news. Its been posted here by Feed Reader and we had no controls and checking on it. And because News posted here will be deleted automatically after 21 days, threads are closed so that no one spend time to post and discuss here. You can always check the source and discuss in their site.
In a comprehensive public briefing, the organization examined the regulatory framework governing upcoming pharmaceutical approvals, warning that extensive administrative mandates threaten to undermine reproductive autonomy. HRW emphasized that while authorizing medical abortion pills represents a legal step forward following previous efforts to approve abortion pills for the first time, the proposed implementation rules impose unnecessary procedural barriers.
These restrictions include mandatory in-person multi-visit waiting periods, restrictive provider limitations, and third-party authorization requirements that disproportionately burden rural residents and adolescents seeking confidential care within a cultural landscape where reproductive healthcare has historically faced intense social stigma and institutional caution.
The debate over abortion access stems from the historic February 2019 decision by the Constitutional Court of Korea ruling that the criminalization of abortion violated women’s constitutional rights to bodily autonomy and privacy, ordering the legislature to enact a revised legal framework. Despite the constitutional mandate, legislative gridlock left a legal vacuum where abortion remained formally unregulated for years while remaining accessible under constrained clinical guidelines. The World Health Organization (WHO) classifies medical abortion drugs as essential medicines that can be safely managed through primary healthcare settings, establishing global standards that advocacy groups cite against local restrictions.
HRW highlighted that international human rights law protects access to safe and legal abortion as a fundamental component of the right to health, non-discrimination, and privacy. The organization urged the South Korean government to revise the 2027 regulatory proposal by removing mandatory hospitalization rules, eliminating spousal or parental consent obstacles, and ensuring that abortion medications are distributed through standard pharmaceutical channels without prohibitive pricing structures.
For additional background on the legal evolution of reproductive rights in the region, previous reporting examines the ongoing implementation hurdles following the Constitutional Court of Korea striking down criminal abortion laws.
The post Human Rights Watch criticizes restrictive regulations in South Korean medication abortion proposal appeared first on JURIST - News.
Continue reading...
Note: We don't have any responsibilities about this news. Its been posted here by Feed Reader and we had no controls and checking on it. And because News posted here will be deleted automatically after 21 days, threads are closed so that no one spend time to post and discuss here. You can always check the source and discuss in their site.